Conference Reports for NATAP

19th European AIDS Conference October 18th-21st , 2023 Warsaw, Poland Back

Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities - press release       - Three-Year Outcomes from the BICSTaR Study Further Demonstrate the Consistent Efficacy and Safety Profile of Biktarvy, Providing Insights for HIV Clinical Care - Link to full press release https://www.gilead.com/news-and-press/press-room/press-releases/2023/10/real-world-evidence-reinforces-biktarvy-as-a-long-term-treatment-option-with-a-high-barrier-to-resistance-for-people-with-hiv-and-a-range-of-comorbid